Original Article | Clinical Studies
FLT3 inhibitor maintenance after allogeneic stem cell transplantation in FLT3-mutated acute myeloid leukemia (AML) patients
Gong He, Erika Belmont, Theodore Karrison, Wendy Stock, James L. LaBelle, Satyajit Kosuri, Richard A. Larson, Justin P. Kline, Peter A. Riedell, Mariam Nawas, Michael R. Bishop, Hongtao Liu